Neal Ready

Neal Ready

UNVERIFIED PROFILE

Are you Neal Ready?   Register this Author

Register author
Neal Ready

Neal Ready

Publications by authors named "Neal Ready"

Are you Neal Ready?   Register this Author

76Publications

2183Reads

23Profile Views

Role of induction chemotherapy in sinonasal malignancies: a systematic review.

Int Forum Allergy Rhinol 2019 02 9;9(2):212-219. Epub 2018 Nov 9.

Division of Head and Neck Surgery & Communication Sciences, Department of Surgery, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/alr.22229
Publisher Site
http://dx.doi.org/10.1002/alr.22229DOI Listing
February 2019

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

J Clin Oncol 2017 Dec 12;35(35):3924-3933. Epub 2017 Oct 12.

Leora Horn, Vanderbilt-Ingram Cancer Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Everett E. Vokes, University of Chicago, Chicago, IL; Esther Holgado, Hospital De Madrid, Norte Sanchinarro, Madrid; Enriqueta Felip, Hospital Universitari Vall d'Hebron, Barcelona; Luis Paz-Ares, Hospital Universitario Virgen Del Rocio, Seville, Spain; Neal Ready, Duke University Medical Center, Durham, NC; Martin Steins, Thoraxklinik-Heidelberg gGmbH, Heidelberg; Martin Kohlhäeufl, Robert-Bosch-Krankenhaus, Stuttgart; Martin Reck, LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Wilfried E.E. Eberhardt, University Hospital and Ruhrlandclinic, University of Duisburg-Essen, Essen, Germany; Elena Poddubskaya, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Adam Pluzanski, Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warsaw, Poland; Karen L. Reckamp, City of Hope, Duarte, CA; Marco A. Burgio and Lucio Crinò, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Scientifico Romagnolo Per lo Studio e la Cura dei Tumori, Meldola, Italy; David Waterhouse, Oncology Hematology Care (OHC)/US Oncology, Cincinnati, OH; Fabrice Barlesi, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Marseille; Jérôme Fayette, Léon Bérard, Lyon, France; Scott Antonia, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Oscar Arrieta, Instituto Nacional De Cancerologia, Mexico City, Mexico; Naiyer Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; William J. Geese, Ang Li, Anne Blackwood-Chirchir, and Diane Healey, Bristol-Myers Squibb, Princeton, NJ; and Julie Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.3062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075826PMC
December 2017

Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.

J Clin Oncol 2017 Sep 11;35(25):2885-2892. Epub 2017 May 11.

Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.4758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578390PMC
September 2017

Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.

Clin Lung Cancer 2017 07 21;18(4):e259-e265. Epub 2016 Nov 21.

Department of Radiation Oncology, Tulane University School of Medicine, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.11.008DOI Listing
July 2017

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.

N Engl J Med 2017 06;376(25):2415-2426

From the Ohio State University Comprehensive Cancer Center, Columbus (D.P.C.); LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.), and Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.) - both in Germany; Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas and Universidad Complutense, Madrid (L.P.-A., J.C.J.), Vall d'Hebron University Hospital, Barcelona (E.F.), and Hospital Universitario Insular de Gran Canaria, Las Palmas (D.R.-A.) - all in Spain; H. Lee Moffitt Cancer Center, Tampa, FL (B.C.); Vanderbilt University Medical Center, Nashville (L. Horn); Antoni van Leeuwenhoek Ziekenhuis, Amsterdam (M.M.H.), and University of Groningen, Universitair Medisch Centrum Groningen, Groningen (T.J.N.H.) - both in the Netherlands; Prof. Dr. Ion Chiricuta Institute of Oncology and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania (T.-E.C.); Baptist Health Lexington, Lexington, KY (F.B.); Duke University, Durham, NC (N.R.); Lehigh Valley Health Network, Allentown (S.N.), Fox Chase Cancer Center, Philadelphia (H.B.), and University of Pittsburgh Medical Center Cancer Center, Pittsburgh (L.C.V., M.A.S.) - all in Pennsylvania; Juravinski Cancer Centre, Hamilton, ON, Canada (R.J.); Oncology Department, Lausanne University Hospital, Lausanne, Switzerland (S.P.); Santa Maria Hospital, Terni, Italy (E.M.); Hollings Cancer Center, Charleston, SC (J.M.W.); Department of Thoracic-Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (G.R.B.); Klinika Pneumologie a Hrudní Chirurgie, Nemocnice Na Bulovce, Prague, Czech Republic (L. Havel, J.K.); and Bristol-Myers Squibb, Princeton, NJ (H.C., W.J.G., P.B., A.C.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1613493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487310PMC
June 2017

Adaptive planning using positron emission tomography for locally advanced lung cancer: A feasibility study.

Pract Radiat Oncol 2016 Mar-Apr;6(2):96-104. Epub 2015 Oct 23.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2015.10.009DOI Listing
January 2017

Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.

Cancer Invest 2017 Jan 2;35(1):32-35. Epub 2016 Dec 2.

a Division of Medical Oncology, Department of Medicine , Duke University Medical Center , Durham , North Carolina , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2016.1253710DOI Listing
January 2017

Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach.

Cancer Res 2016 12 20;76(24):7078-7088. Epub 2016 Oct 20.

School of Mathematics, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-1054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432417PMC
December 2016

Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 09 27;34(25):2980-7. Epub 2016 Jun 27.

Scott Gettinger, Yale Cancer Center, New Haven, CT; Naiyer A. Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; Laura Q. Chow, University of Washington, Seattle, WA; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Julie Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Neal Ready, Duke University Medical Center, Durham, NC; David E. Gerber, University of Texas Southwestern Medical Center, Dallas, TX; Frances A. Shepherd, Princess Margaret Cancer Centre, Toronto; Rosalyn A. Juergens, Juravinski Cancer Centre at McMaster University, Hamilton; Scott A. Laurie, Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; Scott Antonia, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Jonathan W. Goldman, University of California, Los Angeles, Los Angeles, CA; and Faith E. Nathan, Yun Shen, and Christopher T. Harbison, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.9929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569692PMC
September 2016

Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer.

Lung Cancer 2016 08 25;98:76-78. Epub 2016 May 25.

Department of Radiation Oncology, Duke University, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.05.014DOI Listing
August 2016

Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.

Int J Cancer 2016 Jun 30;138(11):2592-601. Epub 2016 Jan 30.

Duke Cancer Institute, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29991DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294935PMC
June 2016

Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.

Pract Radiat Oncol 2015 Mar-Apr;5(2):79-84. Epub 2014 Jun 14.

Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2014.05.002DOI Listing
December 2015

Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.

Int J Radiat Oncol Biol Phys 2015 Dec 15;93(5):997-1004. Epub 2015 Sep 15.

Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.09.007DOI Listing
December 2015

Surrogate clinical endpoints to predict overall survival in non-small cell lung cancer trials-are we in a new era?

Transl Lung Cancer Res 2015 Dec;4(6):804-8

Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.05.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700223PMC
December 2015

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Oct 27;373(17):1627-39. Epub 2015 Sep 27.

From the Fox Chase Cancer Center, Philadelphia (H.B.); Hospital Universitario Virgen del Rocio, Seville (L.P.-A.), Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (E.F.), and Hospital de Madrid, Norte Sanchinarro, Madrid (E.H.) - all in Spain; Vanderbilt-Ingram Cancer Center (L.H.), and Sarah Cannon Research Institute and Tennessee Oncology (D.R.S.) - both in Nashville; Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.) and Robert-Bosch-Krankenhaus Stuttgart, Gerlingen (M.K.) - both in Germany; Duke University Medical Center, Durham, NC (N.E.R.); University of Washington, Seattle (L.Q.C.); University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Marseille (F.B.), Centre Léon Bérard, Lyon (J.F.), and Centre Hospitalier Universitaire de Rennes, Rennes (H.L.) - all in France; Instituto Nacional de Cancerologia, Mexico City (O.A.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Forlì-Cesena (M.A.B.), and Ospedale di Perugia, Perugia (L.C.) - both in Italy; N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); University of Texas Southwestern Medical Center, Dallas (D.E.G.); Yale Comprehensive Cancer Center, New Haven, CT (S.N.G.); Memorial Sloan Kettering Cancer Center, New York (C.M.R., N.R.); University of Texas M.D. Anderson Cancer Center, Houston (G.R.B.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.J.A.); Bristol-Myers Squibb, Princeton, NJ (C.D., C.T.H., F.G.F.); and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.R.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1507643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705936PMC
October 2015

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Jul 31;373(2):123-35. Epub 2015 May 31.

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.B.); the City of Hope Comprehensive Cancer Center, Duarte, CA (K.L.R.); the Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam (P.B.), Erasmus MC Cancer Institute, Rotterdam (J.G.A.), and Ziekenhuis Amphia, Breda (J.G.A.) - all in the Netherlands; the University Hospital of Perugia, Perugia (L.C.), and the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - both in Italy; the Department of Medical Oncology, West German Cancer Center, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen (W.E.E.E.), the Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.), and the LungenClinic Grosshansdorf, Grosshansdorf (M.R.) - all in Germany; the N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); the H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.A.); the Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland (A.P.); the University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); the Hospital Madrid Norte Sanchinarro (E.H.), the Hospital Universitario Fundación Jiménez Díaz, Madrid (M.D.), and the Hospital Universitario Virgen Del Rocío, Seville (L.P.-A.) - all in Spain; Oncology Hematology Care, Cincinnati (D.W.); the Duke University Medical Center, Durham, NC (N.R.); Massachusetts General Hospital, Boston (J.G.); Centro Internacional de Estudios Clinicos, Santiago, Chile (O.A.F.); Nemocnice Na Bulovce, Prague, Czech Republic (L.H.); Bristol-Myers Squibb, Princeton, NJ (C.B., C.T.H., B.L.); and the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681400PMC
July 2015

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).

J Clin Oncol 2015 May 2;33(15):1660-5. Epub 2015 Mar 2.

Neal E. Ready and Jeffrey Crawford, Duke University Medical Center; Herbert H. Pang and Lin Gu, Alliance Statistics and Data Center, Duke University Medical Center, Durham; Antonius A. Miller, Wake Forest University Medical Center, Winston Salem, NC; Gregory A. Otterson, Ohio State University Medical Center, Columbus, OH; Sachdev P. Thomas, Illinois Oncology Research Association Community Clinical Oncology Program, Illinois Cancer Care, Peoria; Everett E. Vokes, University of Chicago, Chicago, IL; Maria Baggstrom, Washington University School of Medicine, St Louis, MO; Gregory A. Masters, Christiana Healthcare Services, Christiana Hospital, Newark, DE; Stephen L. Graziano and Jeffrey Bogart, State University of New York Upstate Medical University, Syracuse, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.3105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429175PMC
May 2015

Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.

Cancer 2015 Feb 3;121(4):598-604. Epub 2014 Oct 3.

Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
https://www.astro.org/uploadedFiles/Main_Site/News_and_Media
Web Search
http://doi.wiley.com/10.1002/cncr.29095
Publisher Site
http://dx.doi.org/10.1002/cncr.29095DOI Listing
February 2015

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2015 Feb 20;75(2):343-52. Epub 2014 Dec 20.

Duke Cancer Institute, Duke University Medical Center, Box 3052, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2647-xDOI Listing
February 2015

Prognostic validation of the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in inoperable non-small-cell lung cancer.

J Thorac Oncol 2013 Dec;8(12):1545-50

*Physiotherapy Department, The University of Melbourne, Melbourne, Australia; †Duke Cancer Institute, Durham, North Carolina; and ‡Centre for Heart, Lung, and Vascular Health, School of Health and Exercise Sciences, University of British Columbia, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153013
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000032DOI Listing
December 2013

Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?

J Thorac Cardiovasc Surg 2013 Oct 16;146(4):796-801. Epub 2013 Jul 16.

Department of Radiation Oncology, Duke University School of Medicine, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2013.05.027DOI Listing
October 2013

Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?

Thorac Cancer 2013 05;4(2):123-130

Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA Department of Surgery, Division of Thoracic Surgery, Duke University Medical Center, Durham, NC, USA Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1759-7714.2012.00162.xDOI Listing
May 2013

Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma.

Head Neck 2012 Jun 17;34(6):792-6. Epub 2011 Aug 17.

Division of Otolaryngology-Head and Neck Surgery, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hed.21813
Publisher Site
http://dx.doi.org/10.1002/hed.21813DOI Listing
June 2012

Local failure in resected N1 lung cancer: implications for adjuvant therapy.

Int J Radiat Oncol Biol Phys 2012 Jun 28;83(2):727-33. Epub 2011 Dec 28.

Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.07.018DOI Listing
June 2012

Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.

J Thorac Cardiovasc Surg 2011 Nov;142(5):1175-9

Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002252231100835
Publisher Site
http://dx.doi.org/10.1016/j.jtcvs.2011.07.059DOI Listing
November 2011

Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung cancer: a Brown University oncology group phase II study.

J Thorac Oncol 2011 Aug;6(8):1432-4

Brown University Oncology Group, Alpert Medical School of Brown University, Providence, Rhode Island, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182209043DOI Listing
August 2011

Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).

Cancer Chemother Pharmacol 2010 Nov 4;66(6):1013-7. Epub 2010 Feb 4.

Division of Hematology/Oncology, Roger Williams Hospital, 825 Chalkstone Avenue, Providence, RI 02908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1251-yDOI Listing
November 2010

Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.

Int J Radiat Oncol Biol Phys 2009 Dec 19;75(5):1462-7. Epub 2009 May 19.

Department of Radiation Oncology, Duke University of Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.01.069DOI Listing
December 2009

Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.

Cancer 2009 Nov;115(22):5218-27

Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24625DOI Listing
November 2009

Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumors.

Clin Cancer Res 2009 Jan;15(1):374-81

Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1024DOI Listing
January 2009

Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses.

Am J Clin Oncol 2007 Aug;30(4):361-7

Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI 02903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318033e76aDOI Listing
August 2007

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer.

Lung Cancer 2007 Jul 30;57(1):84-8. Epub 2007 Mar 30.

Department of Medicine, SUNY Upstate Medical University, Regional Oncology Center, 750 E Adams Street, Syracuse, NY 13210, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.02.014DOI Listing
July 2007

Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors.

Clin Cancer Res 2007 Jan;13(2 Pt 1):576-83

Rhode Island Hospital, Brown University, Providence, Rhode Island, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1262DOI Listing
January 2007

Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer.

Cancer 2006 Sep;107(5):1050-4

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22095DOI Listing
September 2006

Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.

J Vasc Interv Radiol 2006 Jul;17(7):1117-24

Department of Diagnostic Imaging, Brown University Medical School, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S105104430760849
Publisher Site
http://dx.doi.org/10.1097/01.RVI.0000228373.58498.6EDOI Listing
July 2006

Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.

Chest 2006 Mar;129(3):738-45

Department of Diagnostic Imaging, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.129.3.738DOI Listing
March 2006

Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer.

Authors:
Neal Ready

Semin Oncol 2005 Apr;32(2 Suppl 3):S35-41

Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.

View Article

Download full-text PDF

Source
April 2005

Gefitinib therapy for non-small cell lung cancer.

Curr Treat Options Oncol 2005 Jan;6(1):75-81

Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.

View Article

Download full-text PDF

Source
January 2005

Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer.

Lung Cancer 2003 Dec;42 Suppl 1:S65-9

Brown University Medical School, Providence, RI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(03)00306-4DOI Listing
December 2003

Adjuvant high-dose interferon therapy for high-risk melanoma.

Arch Dermatol 2003 Dec;139(12):1635-7

Brown University School of Medicine and Veterans Affairs Medical Center, Providence, RI, USA.

View Article

Download full-text PDF

Source
http://archderm.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archderm.139.12.1635DOI Listing
December 2003

Update in non-small cell lung cancer.

Med Health R I 2002 Jan;85(1):7-9

Medical Oncology Group, 1110 Broad Ave., Suite 500, Gulfport, MS 39502-1210, USA.

View Article

Download full-text PDF

Source
January 2002